The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2019
Filed:
Dec. 15, 2016
Applicant:
Janssen Vaccines & Prevention B.v., Leiden, NL;
Inventors:
Johannes Petrus Maria Langedijk, Amsterdam, NL;
Danielle Van Manen, Alphen aan den Rijn, NL;
Jort Vellinga, Leiden, NL;
Frank Wegmann, Leiden, NL;
Benoit Christophe Stephan Callendret, The Hague, NL;
Anders Krarup, Glostrup, DK;
Jörn Stitz, Köln, DE;
Assignee:
Janssen Vaccines & Prevention B.V., Leiden, NL;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); C07K 14/16 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); C12N 15/861 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); C07K 14/005 (2013.01); C07K 14/162 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/5256 (2013.01); C12N 15/861 (2013.01); C12N 2710/10343 (2013.01); C12N 2740/16111 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16171 (2013.01);
Abstract
Synthetic HIV envelope proteins, vectors and compositions thereof, and methods for inducing protective immunity against human immunodeficiency virus (HIV) infection are described. Viral expression vectors encoding the synthetic HIV envelope proteins can be used in vaccines to provide improved protective immunity against HIV.